Harmonization of Zika serological assays and comparative evaluation of two commercial ZIKA IgG ELISA kits

The interpretation for Zika virus serology results is challenging due to high antibody cross reactivity with other flaviviruses.This limits availability of reliable and accurate methods for serosurveillance studies to understand the disease burden.Therefore, we conducted study to harmonize anti-Zika IgG antibody detection assays with 1st WHO International Standard(16/352) and working standard(16/320) for anti-Zika virus antibody.Additionally, evaluatedNuGenTMZIKA-IgG and Novalisa®ZIKA virus IgG-Capture ELISA using a panel of 278 seraFurther, 106 samples positive for other-flavi viruses were taken for assessing cross-reactivity of the assay, all serums were further tested by Zika-PRNT. The results of this study indicates satisfactory performance of both the assays.Serological and neutralization assays were calibrated according to the international standards. This will help in understanding antibody dynamics in serosurveillance and vaccine studies. However the performance of the kits with possibilities of cross-reactivity will have to be verified by coupling ZIKV and DENV specific ELISA.